Developmental Funds are used to foster outstanding cancer research. During the last grant period, Developmental Funds provided essential support for eight outstanding new investigators, supported 31 pilot studies, and helped establish three new Shared Resources. In particular. Developmental Funds helped to strengthen the Division of Public Health Science and Improved interactions between this division and the Divisions of Basic and Clinical Sciences. During the next grant period, CINJ will use Developmental Funds to continue to enhance each of the established research Programs of the center: Cell Death and Survival Signaling;Genomic Instability and Tumor Progression;Cancer Pharmacology and Preclinical Therapeutics;Clinical Investigations;Carcinogenesis and Chemoprevention;and Cancer Prevention and Control. To accomplish this aim. Developmental Funds will be used to help recruit new investigators, develop new Shared Resources, and fund additional pilot projects aimed at fostering transdisciplinary and translational collaborations, within four major CINJ strategic initiatives: (1) to enhance translational research;(2) to enhance basic science depth through collaborative activity with consortium members;(3) to enhance bioinformatics and systems biology through strategic recruitment of bioinformatics and integration of computational biology faculty;and (4) to develop population science research through recruitment and pilot awards, and the incorporation of the State's cancer registry and research into CINJ. The identification of opportunities for developmental funds that are high yield, and possibly high risk, are developed by the Scientific Council, with advice from the internal and External Advisory Boards (see also Section 7.4). We are requesting a total of $600,000 per year in the Developmental Funds category from the CCSG. Specifically, we are requesting $150,000 toward recruitment and support of new faculty level scientists in areas of strategic need;(2) $225,000 to support pilot projects in high-priority and translational research areas;and (3) $225,000 to develop new Shared Resources ($75,000 each for Small Animal Imaging, Metabolomics, and Epidemiology Services) that align with CINJ's scientific growth and needs.

Public Health Relevance

Developmental Funds are critical to a dynamic cancer center as they offer a strong source of support for emerging research initiatives and related Infrastructure. Validation by the CCSG process of plans for the use of Developmental Funds helps garner additional

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA072720-14
Application #
8221725
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
14
Fiscal Year
2012
Total Cost
$757,561
Indirect Cost
$327,293
Name
University of Medicine & Dentistry of NJ
Department
Type
DUNS #
617022384
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Cannioto, Rikki A; LaMonte, Michael J; Kelemen, Linda E et al. (2016) Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. Br J Cancer 115:95-101
Cuellar-Partida, Gabriel; Lu, Yi; Dixon, Suzanne C et al. (2016) Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet 135:741-56
Stapleton, Jerod L; Hillhouse, Joel J; Turrisi, Rob et al. (2016) The Behavioral Addiction Indoor Tanning Screener (BAITS): An Evaluation of a Brief Measure of Behavioral Addictive Symptoms. Acta Derm Venereol 96:552-3
Manne, Sharon; Hudson, Shawna V; Baredes, Soly et al. (2016) Survivorship care experiences, information, and support needs of patients with oral and oropharyngeal cancer. Head Neck 38 Suppl 1:E1935-46
Viola, Adrienne S; Giovenco, Daniel P; Miller Lo, Erin J et al. (2016) A cigar by any other name would taste as sweet. Tob Control 25:605-6
Qin, Bo; Moorman, Patricia G; Alberg, Anthony J et al. (2016) Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr 115:694-702
Zhang, Cen; Liu, Juan; Huang, Grace et al. (2016) Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression. Genes Dev 30:1956-70
Pan, Ji-An; Sun, Yu; Jiang, Ya-Ping et al. (2016) TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Mol Cell 61:720-33
Stapleton, Jerod L; Tatum, Kristina L; Devine, Katie A et al. (2016) Skin Cancer Surveillance Behaviors Among Childhood Cancer Survivors. Pediatr Blood Cancer 63:554-7
Spencer, Kristen R; Mehnert, Janice M (2016) Importance of including patients with comorbidities in clinical trials. Lancet Oncol 17:17-8

Showing the most recent 10 out of 623 publications